Dr. Levis on Gilteritinib in Relapsed/Refractory FLT3-Mutated AML | OncLive
onclive.com
Dr. Levis on Gilteritinib in Relapsed/Refractory FLT3-Mutated AML | OncLive
Mark James Levis, MD, PhD, program leader of Hematologic Malignancies and Bone Marrow Transplant Program at Sidney Kimmel Comprehensive Cancer Center, and professor of oncology, Johns Hopkins Medicine, discusses an analysis of gilteritinib in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia harboring other common co ...
4 months ago
Related Products
Cancer Cell with Gilteritinib
FLT3 Gilteritinib
Venetoclax Gilteritinib Midostaurin Synergetic
#Gilteritinib Mechanism
Astellas Pharma Inc. to Present New Data on XOSPATA (Gilteritinib) Across the FLT3m AML Disease Continuum At ASH 2025 Annual Meeting
Astellas Pharma Inc. to Present New Data on XOSPATA (Gilteritinib) Across the FLT3m AML Disease Continuum At ASH 2025 Annual Meeting
marketscreener.com3 months ago
Dr. Altman on Gilteritinib in Patients With Relapsed/Refractory AML | OncLive
Dr. Altman on Gilteritinib in Patients With Relapsed/Refractory AML | OncLive
onclive.comAug 23, 2017
Top videos
ASH 2022 Triplet Combination of Azacitidine, Venetoclax, and Gilteritinib for Pts With FLT3-Mutated AML: Updated Results From a Phase I/II Study
ASH 2022 Triplet Combination of Azacitidine, Venetoclax, and Gilteritinib for Pts With FLT3-Mutated AML: Updated Results From a Phase I/II Study
vumedi.com
530 viewsJan 5, 2023
Dr Arora on Azacitidine Plus Venetoclax and Gilteritinib in FLT3 Wild-Type AML | OncLive
Dr Arora on Azacitidine Plus Venetoclax and Gilteritinib in FLT3 Wild-Type AML | OncLive
onclive.com
3 months ago
Dr Levis on Maintenance Gilteritinib After ASCT in FLT3-ITD AML | OncLive
Dr Levis on Maintenance Gilteritinib After ASCT in FLT3-ITD AML | OncLive
onclive.com
Jun 11, 2023
Gilteritinib Side Effects
XOSPATA® (gilteritinib) Mechanism of Action
XOSPATA® (gilteritinib) Mechanism of Action
xospatahcp.com
Dec 18, 2020
Dr. Patel on the Role of Gilteritinib in FLT3+ AML
1:15
Dr. Patel on the Role of Gilteritinib in FLT3+ AML
YouTubeOncLive
293 viewsFeb 17, 2020
Understanding the results of MORPHO: gilteritinib as post-transplant maintenance for FLT3-ITD AML
2:03
Understanding the results of MORPHO: gilteritinib as post-transplant maintenance for FLT3-ITD AML
YouTubeVJHemOnc – Video Journal
48 views3 months ago
ASH 2022 Triplet Combination of Azacitidine, Venetoclax, and Gilteritinib for Pts With FLT3-Mutated AML: Updated Results From a Phase I/II Study
ASH 2022 Triplet Combination of Azacitidine, Venetoclax, and Gilter…
530 viewsJan 5, 2023
vumedi.com
Dr Arora on Azacitidine Plus Venetoclax and Gilteritinib in FLT3 Wild-Type AML | OncLive
Dr Arora on Azacitidine Plus Venetoclax and Gilteritinib in FLT…
3 months ago
onclive.com
Dr Levis on Maintenance Gilteritinib After ASCT in FLT3-ITD AML | OncLive
Dr Levis on Maintenance Gilteritinib After ASCT in FLT3-ITD AML | Onc…
Jun 11, 2023
onclive.com
Gilteritinib for FLT3-Mutant AML
10:54
Gilteritinib for FLT3-Mutant AML
2.2K viewsFeb 6, 2019
YouTubeOncLive
Azacitidine, venetoclax & gilteritinib in older/unfit patients with FLT3-mutated AML
2:44
Azacitidine, venetoclax & gilteritinib in older/unfit patients with FLT3-m…
749 viewsJun 20, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
Gilteritinib plus venetoclax for R/R FLT3-mutated AML
6:38
Gilteritinib plus venetoclax for R/R FLT3-mutated AML
516 viewsDec 6, 2020
YouTubeVJHemOnc – Video Journal of Hematology & H…
Is gilteritinib the new breakthrough in the treatment of FLT3-mutated AML?
1:33
Is gilteritinib the new breakthrough in the treatment of FLT3-mutated …
501 viewsJul 25, 2017
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:13
HMAs or chemotherapy with venetoclax and gilteritinib for FLT…
16 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:11
FRIDA study: iadademstat and gilteritinib in FLT3-mutated R/R AML
46 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:31
Azacitidine, venetoclax, and gilteritinib in newly diagnosed FLT…
59 views2 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:43
Gilteritinib monotherapy vs combination therapy in R/R FLT3-…
227 viewsSep 11, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
Dr. Altman on Gilteritinib in Patients With Relapsed/Refractory AML | O…
Aug 23, 2017
onclive.com
3:31
VICEROY study: azacitidine, venetoclax, and gilteritinib in FLT…
50 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:28
Patient-reported outcomes in FLT3-mutated AML patients treated wit…
112 viewsFeb 24, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
Treatment Combinations in FLT3-Mutated AML | OncLive
2 weeks ago
onclive.com
2:35
Gilteritinib, venetoclax, low-dose cytarabine, and actinomycin D in …
226 viewsJun 17, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:15
Dr. Patel on the Role of Gilteritinib in FLT3+ AML
293 viewsFeb 17, 2020
YouTubeOncLive
5:09
MORPHO: gilteritinib as post-transplant maintenance therapy i…
909 viewsJun 14, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:09
Dr Arora on Azacitidine Plus Venetoclax and Gilteritinib in FLT…
83 views3 months ago
YouTubeOncLive
Astellas Pharma Inc. to Present New Data on XOSPATA (Gilteritinib) Ac…
3 months ago
marketscreener.com
2:03
Understanding the results of MORPHO: gilteritinib as post-tran…
48 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
Astellas Pharma Inc. dévoilera de nouvelles données sur XOSPATA …
3 months ago
zonebourse.com
1:20
Gilteritinib for FLT+ R/R AML
140 viewsOct 31, 2019
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:06
Gilteritinib Monotherapy Shows Potential for Treatment of Relapse…
334 viewsAug 8, 2019
YouTubeTargeted Oncology
3:13
Preliminary results from the FRIDA study: iadademstat and gilteritini…
154 viewsJul 2, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:43
What is FLT3-positive AML? What is gilteritinib? #AML
3.5K viewsJun 26, 2023
YouTubeHealthTree University for Blood Cancers
9:39
Alexander Perl, MD: The New FLT3 Inhibitor Gilteritinib is “Well-Toler…
1.7K viewsDec 12, 2016
YouTubeAmerican Society of Hematology
2:46
Update of the ADMIRAL trial: gilteritinib vs salvage chemothera…
192 viewsDec 11, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:35
ADMIRAL trial results: Gilteritinib versus salvage chemotherapy in p…
232 viewsJun 25, 2019
YouTubeecancer
See more videos
Static thumbnail place holder